参考文献:
[1] JoslinEP, Kahn CR. Joslin'sDiabetes Mellitus.Lippincott Williams & Wilkins; 2005.
[2] HirataY. Insulin autoimmunity in a case of spontaneous hypoglycemia [J]. JJpn Diabet Soc, 1970, 13:312-319.
[3] UchigataY, Eguchi Y, Takayama-Hasumi S, et al. Insulin autoimmune syndrome(Hirata disease): clinical features and epidemiology in Japan [J].Diabetes Res Clin Pract, 1994, 22:89-94.
[4] LiuH, Liang S, Li Y, et al. A Novel Type of Extreme Insulin Resistance:Nonhypoglycemic Insulin Autoimmune Syndrome [J]. J Clin EndocrinolMetab, 2021, 106:1051-1061.
[5] UchigataY, Omori Y, Nieda M, et al. HLA-DR4 genotype and insulin-processingin insulin autoimmune syndrome[J]. Lancet, 1992, 340:1467.
[6] UchigataY, Kuwata S, Tokunaga K, et al. Strong association of insulinautoimmune syndrome with HLA-DR4 [J]. Lancet, 1992, 339:393-394.
[7] GoldmanJ, Baldwin D, Rubenstein AH, et al. Characterization of circulatinginsulin and proinsulin-binding antibodies in autoimmune hypoglycemia[J]. The Journal of clinical investigation, 1979, 63:1050-1059.
[8] HirotaY, Ogawa W, Murawaki A, et al. Deterioration of glycaemic controlassociated with anti-insulin antibodies likely induced by healthsupplements [J]. Diabet Med, 2009, 26:948-951.
[9] SakataS, Nagai K, Imai T, et al. A case of diabetes mellitus associatedwith anti-insulin autoantibodies without previous insulin injection[J]. J Endocrinol Invest, 1987, 10:407-411.
[10] HuX, Chen F. Exogenous insulin antibody syndrome (EIAS): a clinicalsyndrome associated with insulin antibodies induced by exogenousinsulin in diabetic patients [J]. Endocr Connect, 2018, 7:R47-R55.